Biocircuits Corp.

Biocircuits Corp. — FDA 510(k) Submissions

Biocircuits Corp. has submitted 8 FDA 510(k) premarket notifications since 1995, of which 8 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Enzyme Immunoassay, Non-radiolabeled, Total Thyroxine, System, Test, Human Chorionic Gonadotropin, Multi-analyte Controls, All Kinds (assayed), Radioimmunoassay, Free Thyroxine, Prostate-specific Antigen (psa) For Management Of Prostate Cancers . Use the specialty filter in the sidebar to narrow results.